Contact eczema;Kontaktekzem

Allergo Journal

Volumn 16, Issue 3, 2007, Pages 176-185

  Brasch, Jochen ^a,g   Becker, Detlef ^b   Aberer, Werner ^c   Bircher, Andreas ^d   Kränke, Birger ^c   Denzer Fürst, Stephanie ^e   Schnuch, Axel ^f  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Venerologie und Allergologie   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; GLUCOCORTICOID;

CLINICAL FEATURE; CONTACT DERMATITIS; DIAGNOSTIC PROCEDURE; HEALTH SURVEY; HUMAN; MORBIDITY; PATHOPHYSIOLOGY; PREVALENCE; PUVA; REVIEW;

EID: 34248380000     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03370636     Document Type: Review

References (86)

1. Aberer W, Kränke B. Nicht ekzematöse Kontakt-dermatitis. Allergo J 2003; 12: 508-12
2. Agner T, Held E. Skin protection programmes. Contact Dermatitis 2002; 47: 253-6
3. Agner T, Menne T. Individual predisposition to irritant and allergic contact dermatitis. In: Rycroft RJG, Menne T, Frosch PJ, Lepoittevin J-P, eds. Textbook of Contact Dermatitis, 3rd edn. Berlin - Heidelberg - New York: Springer, 2001: 173-85
4. Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis 2003; 49: 185-8
5. Amrol D, Keitel D, Hagaman D, Murray J. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol 2003; 91: 563-6
6. Antico A, Soana R. Chronic allergic-like dermatopathies in nickel-sensitive patients. Results of dietary restrictions and challenge with nickel salts. Allergy Asthma Proc 1999; 20: 235-42
7. Behr-Völtzer C, Hamm M, Vieluf D, Ring J. Diätempfehlungen bei Nickelunveträglichkeit. Allergo J 1997; 6: 197-203
8. Brasch J, Geier J. Patch test results in schoolchildren. Results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Contact Dermatitis 1997; 37: 286-93
9. Brehler R, Becker D, Merk H. MELISA - in vitro test for detection of contact allergy? A comment by the German Contact Allergy Group. Hautarzt 1998; 49: 418-9
10. Bresser H. Orale Nickelprovokation und nickelarme Diät. Indikation und praktische Durchführung. Hautarzt 1992; 43: 610-5
11. Cholcha W, Leuschner J, Leuschner F. The tolerability of pale sulfonated shale oil following local and systemic administration. Arzneimittelforschung 1994; 44: 170-7
12. Christophersen J, Menne T, Tanghoj P, Andersen KE, Brandrup F, Kaaber K, Osmundsen PE, Thestrup-Pedersen K, Veien NK. Impact of individual factors on clinical patch test results with special reference to age. Semin Dermatol 1989; 8: 127-9
13. Corsini E, Galli CL. Epidermal cytokines in experimental contact dermatitis. Toxicology 2000; 142: 203-11
14. Diepgen TL, Svensson A, Coenraads PJ. Therapie von Handekzemen. Was können wir von publizierten klinischen Studien lernen? Hautarzt 2005; 56: 224-31
15. Emtestam L, Zetterquist H, Olerup O. HLA-DR, -DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 1993; 100: 271-4
16. Forsbeck M, Skog E, Ytterborn KH. The frequency of allergic diseases among relatives to patients with allergic eczematous contact dermatitis. A preliminary report. Acta Derm Venereol (Stockh) 1966; 46: 149-52
17. Fowler JF. Disulfiram is effective for nickel allergic hand eczema. Am J Contact Dermatitis 1992; 3: 175-8
18. Frosch PJ, Rustemeyer T, Schnuch A. Kontaktdermatitis I. Hautarzt 1996; 47: 874-82
19. Frosch PJ, Rustemeyer T, Schnuch A. Kontaktdermatitis II. Hautarzt 1996; 47: 945-61
20. Girolomoni G, Gisondi P, Ottaviani C, Cavani A. Immunoregulation of allergic contact dermatitis. J Dermatol 2004; 31: 264-70
21. Gorbachev AV, Fairchild RL. Induction and regulation of T-cell priming for contact hypersensitivity. Crit Rev Immunol 2001; 21: 451-72
22. Granlund H, Erkko P, Reitamo S. Comparison of the influence of cyclosporine and topical betamethasone-17,21diproprionate treatment on quality of life in chronic hand eczema. Acta Derm Venereol (Stockh) 1997; 77: 54-8
23. Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol (Stockh) 1998; 78: 40-3
24. Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004; 51: 297-310
25. Hegewald J, Uter W, Pfahlberg A, Geier J, Schnuch A. A multifactorial analysis of concurrent patch-test reactions to nickel, cobalt, and Chromate. Allergy 2005; 60: 372-8
26. Hermann-Kunz E. Allergische Krankheiten in Deutschland. Ergebnisse einer repräsentativen Studie. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2000; 43: 400-6
27. Ikäheimo I, Tiilikainen A, Karvonen J, Silvennoinen-Kassinen S. HLA-DQA1 and -DQB1 loci in nickel allergy patients. Int Arch Allergy Immunol 1993; 100: 248-50
28. Kaaber K, Menné T, Veien N, Hougaard P.Treatment of nickel dermatitis with Antabus; a double blind study. Contact Dermatitis 1983; 9: 297-9
29. King CM, Chalmers RJG. A double blind study of superficial radio-therapy in chronic palmar eczema. Br J Dermatol 1984; 111: 445-9
30. Kränke B, Szolar-Platzer C, Komericki P, Derhaschnig J, Aberer W. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer. Contact Dermatitis 1997; 36: 212-5
31. Kutting B, Drexler H. Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update to criteria of evidence-based medicine. Int Arch Occup Environ Health 2003; 76: 253-9
32. Lantinga H, Nater JP, Coenraads PJ. Prevalence, incidence and course of eczema on the hands and forearms in a sample of the general population. Contact Dermatitis 1984; 10: 135-9
33. Levin C, Maibach HI. An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. Contact Dermatitis 2000; 43: 317-21
34. Levin C, Zhai H, Bashir S, Chew AL, Anigbogu A, Stern R, Maibach H. Efficacy of corticosteroids in acute experimental irritant contact dermatitis. Skin Res Technol 2001; 7: 214-8
35. Lindelöf B, Wrangsjö K, Lidén S. A double-blind study of grenz ray therapy in chronic eczema of the hands. Br J Dermatol 1987; 117: 77-80
36. Lodén M. Barrier recovery and influence of irritant stimuli in skin treated with a moisterizing cream. Contact Dermatitis 1997; 36: 256-60
37. Luger T, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, Krutmann J, Niedner R, Röcken M, Ruzicka T, Schwarz T. Topische Dermatotherapie mit Glukokortikoiden - therapeutischer Index. J Dtsch Dermatol Ges 2004; 2: 629-34
38. Luger TA, Bieber T, Meurer M, Mrowietz U, Schwarz T, Simon J, Werfel T, Zuberbier T. Therapie des atopischen Ekzems mit Calcineurinantagonisten. J Dtsch Dermatol Ges 2005; 3: 385-91
39. Luger TA, Gollnick H. Stellungnahme der Deutschen Dermatologischen Gesellschaft (DDG) zur Entscheidung der amerikanischen Arzneimittelbehörde über die Verwendung von Pimecrolimus-Creme und Tacrolimus-Salbe zur Behandlung der Atopischen Dermatitis (Neurodermitis). JDDG 2005; 3: 415-6
40. Lynde CW. Moisturizers: what they are and how they work. Skin Ther Lett 2001; 6: 3-5
41. Martin S, Weltzien HU. T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 1994; 104: 10-6
42. Meding B. Epidemiology of hand eczema in an industrial city. Acta Derm Venereol Suppl (Stockh) 1990; 153: 2-43
43. Meingassner JG, Fahrngruber H, Bavandi A. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. J Invest Dermatol 2003; 121: 77-80
44. Menezes-de-Padua CA, Schnuch A, Lessmann H, Geier J, Pfahlberg A, Uter W. Contact allergy to neomycin sulfate - results of a multifactorial analysis. 2005; Pharmacoepidemiol Drug Saf 2005; 14: 725-33
45. Menné T, Holm NV. Nickel allergy in a female twin population. Int J Dermatol 1983; 22: 22-8
46. Menné T, Holm NV. Genetic susceptibility in human allergic contact sensitization. Semin Dermatol 1986; 5: 301-6
47. Menné T, Holm NV. Genetic aspects of nickel sensitization. In: Maibach HI, Menné T, eds. Nickel and the Skin: Immunology and Toxicology: Boca Raton: CRC Press, 1989: 101-7
48. Mork NJ, Austad J. Short-wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands. Acta Derm Venereol (Stockh) 1983; 63: 87-9
49. Mozzanica N, Rizzolo L, Veneroni G, Diotti R, Hepeisen S, Finzi AF. HLA-A,B,C and DR antigens in nickel contact sensitivity. Br J Dermatol 1990; 122: 309-13
50. Niedner R. Grundlagen einer rationalen Therapie mit externen Glukokortikosteriden. Hautarzt 1991; 42: 337-46
51. Nielsen NH, Linneberg A, Menne T, Maden F, Frolund L, Dirksen A, Jorgensen T- Allergic contact sensitization in an adult Danish population: two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm Venereol (Stockh) 2001; 81: 31-4
52. Nielsen NH, Menné T. Allergic contact sensitization in an unselected danish population - the Glostrup allergy study, Denmark. Acta Derm Venereol (Stockh) 1992; 72: 456-60
53. Odia S, Vocks E, Rakoski J, Ring J. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol (Stockh) 1996; 76: 472-4
54. Parker D, Sommer G, Turk JL. Variation in guinea pig responsiveness. Cell Immunol 1975; 18: 233-8
55. Petering H, Breuer C, Herbst R, Kapp A, Werfel T. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004; 50: 68-72
56. Pion IA, Koenig KL, Lim HW. Is dermatologic usage of coal tar carcinogenic? A review of the literature. Dermatol Surg 1995; 21: 227-31
57. Queille-Roussel C, Graeber M, Thurston M, Lachapelle JM, Decroix J, Cuyper C de, Ortonne JP. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. Contact Dermatitis 2000; 42: 349-70
58. Reich K, Westphal G, König IR, Mössner R, Krüger U, Ziegler A, Neumann C, Schnuch A.Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene. J Allergy Clin Immunol 2003; 112: 1191-4
59. Santamaria Babi LF, Picker U, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, Hauser C. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995; 181: 1935-40
60. Saripalli YV, Gadzia JE, Belsito DV. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003; 49: 477-82
61. Sato K, Kusaka Y, Zhang Q, Yanagihara M, Ueda K, Morihiro H, Ishii Y. Investigation of the association between mercury sensitization and HLA-DR6. Contact Dermatitis 1996; 34: 295
62. Schmid MH, Korting HC. Coal tar, pine tar and sulfonated shale oil preparations: comparative activity, efficacy and safety. Dermatology 1996; 193: 1-5
63. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol (Stockh) 1998; 78: 318-9
64. Schnuch A, Lessmann H, Geier J, Frosch PJ, Uter W; IVDK. Contact allergy to fragrances: frequencies of sensitization from 1996 to 2002. Results of the IVDK*. Contact Dermatitis 2004; 50: 65-76
65. Schnuch A, Uter W, Geier J, Gefeller O. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug utilisation research (CE-DUR) approach. Contact Dermatitis 2002; 47: 32-9
66. Schnuch A, Aberer W, Agathos M, Brasch J, Frosch PJ, Fuchs T, Richter G. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epicutantests mit Kontaktallergenen. Hautarzt 2001; 101: 864-6
67. Schnuch A, Westphal GA, Müller MM, Schulz TG, Geier J, Brasch J, Merk HF, Kawakubo Y, Richter G, Koch P, Fuchs T, Gutgesell C, Reich K, Gebhardt M, Becker D, Grabbe J, Sebastiani S, Albanesi C, De PO, Puddu P, Cavani A, Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002; 293: 552-9
68. Schnuch A, Westphal GA, Müller MM, Schulz TG, Geier J, Brasch J, Merk HF, Kawakubo Y, Richter G, Koch P, Fuchs T, Gutgesell C, Reich K, Gebhardt M, Becker D, Grabbe J, Szliska C, Lischka G, Aberer W, Hallier E. Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. Contact Dermatitis 1998; 38: 209-11
69. Schooten FJ van, Godschalk R. Coal tar therapy. Is it carcinogenic? Drug Saf 1996; 15: 374-7
70. Silvennoinen-Kassinen S, Ikäheimo I, Tiilikainen A. TAP1 and TAP2 genes in Nickel allergy. Int Arch Allergy Immunol 1997; 114: 94-6
71. Sjövall P, Christensen OB. Local and systemic effect of ultraviolet irradiation (UVA and UVB) on human allergic contact dermatitis. Acta Derm Venereol (Stockh) 1986; 66: 290-4
72. Sjövall P, Christensen OB. Treatment of chronic hand eczema with UV-B Handylux in the clinic and at home. Contact Dermatitis 1994; 31: 5-8
73. Smit HA, Coenraads PJ. A retrospective cohort study on the incidence of hand dermatitis in nurses. Int Arch Occup Environ Health 1993; 64: 541-4
74. Ulfgren AK, Klareskog L, Lindberg M. An immunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis. Acta Derm Venereol (Stockh) 2000; 80: 167-70
75. Uter W. Epidemiologie und Prävention von Handekzemen in Feuchtberufen am Beispiel des Friseur-handwerks. Osnabrück: Universitätsverlag Rasch, 1999.
76. Uter W, Ludwig A, Balda B-R, Schnuch A, Schäfer T, Wichmann HE, Ring J. Prävalenz von Kontaktsensibilisierungen gegen Allergene der "Standardreihe" - Vergleich von KORA-Studiendaten mit dem IVDK-Register. Allergo J 2001; 10: 326-8
77. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long term, intermittent treatment of chronic hand eczem with mometasone furoate. Br J Dermatol 1999; 140: 882-6
78. Walker FB, Smith PD, Maibach HI. Genetic factors in human allergic contact dermatitis. Int Arch Allergy Appl Immunol 1967; 32: 453-62
79. Warshaw E, Lee G, Storrs FJ. Hand dermatitis: a review of clinical features, therapeutic options, and long-term outcomes. Am J Contact Dermatitis 2003; 14: 119-37
80. Wassilew SW, Hautschutz am Arbeitsplatz. In: Plewig G, Przybilla B, Hrsg. Fortschritte der praktischen Dermatologie und Venerologie. Berlin - Heidelberg: Springer, 1997: 182-5
81. Westphal GA, Reich K, Schulz TG, Neumann C, Hallier E, Schnuch A. N-acetyltransferases 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy. Br J Dermatol 2000; 142: 1121-7
82. Westphal GA, Schnuch A, Moessner R, Konig IR, Kränke B, Hallier E, Ziegler A, Reich K. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003; 48: 93-8
83. White SI, Friedmann PS, Stratton A. HLA antigens and Langerhans cell density in contact dermatitis. Br J Dermatol 1986; 115: 447-52
84. Willis CM, Stephens CJ, Wilkinson JD. Epidermal damage induced by irritants in man: a light and electron microscopic study. J Invest Dermatol 1989; 93: 695-9
85. Willis CM, Young E, Brandon DR, Wilkinson JD. Immunopathological and ultrastructural findings in human allergic and irritant contact dermatitis. Br J Dermatol 1986; 115: 305-16
86. Zhai H, Maibach HI. Moisturizers in preventing irritant contact dermatitis: an overview. Contact Dermatitis 1998; 38: 241-4